<DOC>
	<DOC>NCT00960141</DOC>
	<brief_summary>A study of the ability of montelukast to improve signs and symptoms of seasonal allergic rhinitis compared with placebo. Loratadine is included in the study as an active control.</brief_summary>
	<brief_title>A Study Investigating the Effect of Montelukast in Patients With Seasonal Allergic Rhinitis (MK-0476-192)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis, Allergic, Seasonal</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<criteria>Patient has a documented clinical history of seasonal allergic rhinitis symptoms that become worse during the study season Patient is a nonsmoker Patient is in good mental and physical health Patient is hospitalized Patient is a woman who is &lt;8 weeks postpartum or is breast feeding Patient intends to move or vacation away during the study Patient is a current or past abuser of alcohol or illicit drugs</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>